Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans
Deguil, J., Ravasi, L., Auffret, A., Babiloni, C., Bartres Faz, D., Bragulat, V., Cassé-Perrot, C., Colavito, V., Herrero Ezquerro, M.T., Lamberty, Y., Lanteaume, L., Pemberton, D., Pifferi, F., Richardson, J.C., Schenker, E., Blin, O., tarragon, E., Bordet, R.
Published in Drug discovery today. Technologies (01.09.2013)
Published in Drug discovery today. Technologies (01.09.2013)
Get full text
Journal Article
Impact d’un stress hypoxique sur la mémoire : évaluation dans un modèle murin
Alves Pires, C, Deguil, J, Caillierez, R, Bordet, R, Charley, C. Monaca, Buee, L
Published in Neurophysiologie clinique (01.04.2013)
Published in Neurophysiologie clinique (01.04.2013)
Get full text
Journal Article
A cell-permeable peptide inhibitor TAT-JBD reduces the MPP super(+)-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats
Pain, S, Barrier, L, Deguil, J, Milin, S, Piriou, A, Fauconneau, B, Page, G
Published in Toxicology (Amsterdam) (14.01.2008)
Published in Toxicology (Amsterdam) (14.01.2008)
Get full text
Journal Article
Activation of the protein p7OS6K via ERK phosphorylation by cholinergic muscarinic receptors stimulation in human neuroblastoma cells and in mice brain
Deguil, Julie, Perault-Pochat, Marie-Christine, Chavant, François, Lafay-Chebassier, Claire, Fauconneau, Bernard, Pain, Stéphanie
Published in Toxicology letters (10.11.2008)
Published in Toxicology letters (10.11.2008)
Get full text
Journal Article